| excitatory amino acid agents | Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids. (12 Dec 1998) |
|---|---|
| keratolytic agents | Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (12 Dec 1998) |
| uncoupling agents | Chemical agents that uncouple oxidation from phosphorylation in the metabolic cycle so that ATP synthesis does not occur. Included here are those ionophores that disrupt electron transfer by short-circuiting the proton gradient across mitochondrial membranes. (12 Dec 1998) |
| fertility agents | Drugs used to increase fertility or to treat infertility. (12 Dec 1998) |
| fertility agents, female | Compounds which increase the capacity to conceive in females. (12 Dec 1998) |
| fertility agents, male | Compounds which increase the capacity of the male to induce conception. (12 Dec 1998) |
| flavoring agents | Pharmaceutical or other preparations for improving the taste of a food or medicine. (12 Dec 1998) |
| foamy agents | Retroviruses of the subfamily Spumavirinae, found in primates and other mammals; so named because of lacelike changes produced in monkey kidney cells; syncytia are also produced. Synonym: foamy agents. (05 Mar 2000) |
| food colouring agents | Natural or synthetic dyes used as colouring agents in processed foods. (12 Dec 1998) |
| leprostatic agents | Substances that suppress mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions. (12 Dec 1998) |
| lipids and antilipaemic agents | A collective grouping for lipids and substances that maintain normal blood lipid levels. (12 Dec 1998) |
| lipotropic agents | Endogenous factors or drugs that act on fat metabolism by hastening the removal of or decreasing the deposit of fat in the liver. (12 Dec 1998) |
| lung perfusion agents | <radiology> Tc-99m MAA (macro-aggregated albumin), Tc-99m HAM (human albumin microspheres), dose 4 mCi, particles, size 10 - 90 m, number 200,000 - 400,000, effect 1 : 1000 arterioles embolised (12 Dec 1998) |
| lung ventilation agents | <radiology> Xe-133, most commonly used, Xe-127, t = 36.4 days; photons @ 172, 203, 375 keV, can image V after Q, Kr-81m, very expensive, t = 13 sec; photon 190 keV, can repeat V in each projection, Tc-99m DTPA aerosol, can image V in mult. Projections, image Q after V, 1 mCi most likely to be 50-75 mrad to lung, V/Q imaging (12 Dec 1998) |
| luteolytic agents | Chemical compounds causing corpus luteum regression or degeneration. (12 Dec 1998) |